Increased susceptibility of IgA-deficient mice to pulmonary francisella tularensis live vaccine strain infection

Infection and Immunity

Volumn 81, Issue 9, 2013, Pages 3434-3441

  Furuya, Yoichi ^a   Kirimanjeswara, Girish S ^a,b   Roberts, Sean ^a   Metzger, Dennis W ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 12;

ADAPTIVE IMMUNITY; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL LOAD; BACTERIAL STRAIN; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; COLONY FORMING UNIT; FEMALE; FRANCISELLA TULARENSIS; FRANCISELLA TULARENSIS LIVE VACCINE STRAIN; HUMORAL IMMUNITY; IMMUNOGLOBULIN A DEFICIENCY; INFECTION SENSITIVITY; INNATE IMMUNITY; INTERFERON PRODUCTION; LUNG INFECTION; MOUSE; MUCOSAL IMMUNITY; NATURAL KILLER CELL; NONHUMAN; PRIMARY INFECTION; PRIORITY JOURNAL; SURVIVAL; SURVIVAL RATE; TULAREMIA;

EID: 84884245516     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00408-13     Document Type: Article

References (31)

1. Oyston PC, Sjostedt A, Titball RW. 2004. Tularaemia: bioterrorism defence renews interest in Francisella tularensis. Nat. Rev. Microbiol. 2:967-978.
2. Federal Register. 2012. Possession, use, and transfer of select agents and toxins; biennial review. Final rule. Fed. Regist. 77:61083-61115.
3. Brandtzaeg P. 1989. Overview of the mucosal immune system. Curr. Top. Microbiol. Immunol. 146:13-25.
4. Arulanandam BP, Raeder RH, Nedrud JG, Bucher DJ, Le J, Metzger DW. 2001. IgA immunodeficiency leads to inadequate Th cell priming and increased susceptibility to influenza virus infection. J. Immunol. 166:226-231.
5. Rodriguez A, Tjarnlund A, Ivanji J, Singh M, Garcia I, Williams A, Marsh PD, Troye-Blomberg M, Fernandez C. 2005. Role of IgA in the defense against respiratory infections: IgA deficient mice exhibited increased susceptibility to intranasal infection with Mycobacterium bovis BCG. Vaccine 23:2565-2572.
6. Tjarnlund A, Rodriguez A, Cardona PJ, Guirado E, Ivanyi J, Singh M, Troye-Blomberg M, Fernandez C. 2006. Polymeric IgR knockout mice are more susceptible to mycobacterial infections in the respiratory tract than wild-type mice. Int. Immunol. 18:807-816.
7. Rodriguez A, Rottenberg M, Tjarnlund A, Fernandez C. 2006. Immunoglobulin A and CD8 T-cell mucosal immune defenses protect against intranasal infection with Chlamydia pneumoniae. Scand. J. Immunol. 63:177-183.
8. Baron SD, Singh R, Metzger DW. 2007. Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion. Infect. Immun. 75:2152-2162.
9. Murthy AK, Sharma J, Coalson JJ, Zhong G, Arulanandam BP. 2004. Chlamydia trachomatis pulmonary infection induces greater inflammatory pathology in immunoglobulin A deficient mice. Cell. Immunol. 230:56-64.
10. Hanson LA, Bjorkander J, Carlsson B, Roberton D, Soderstrom T. 1988. The heterogeneity of IgA deficiency. J. Clin. Immunol. 8:159-162.
11. Buckley RH. 1975. Clinical and immunologic features of selective IgA deficiency. Birth Defects Orig. Artic. Ser. 11:134-142.
12. Rawool DB, Bitsaktsis C, Li Y, Gosselin DR, Lin Y, Kurkure NV, Metzger DW, Gosselin EJ. 2008. Utilization of Fc receptors as a mucosal vaccine strategy against an intracellular bacterium, Francisella tularensis. J. Immunol. 180:5548-5557.
13. Kirimanjeswara GS, Golden JM, Bakshi CS, Metzger DW. 2007. Prophylactic and therapeutic use of antibodies for protection against respiratory infection with Francisella tularensis. J. Immunol. 179:532-539.
14. Mara-Koosham G, Hutt JA, Lyons CR, Wu TH. 2011. Antibodies contribute to effective vaccination against respiratory infection by type A Francisella tularensis strains. Infect. Immun. 79:1770-1778.
15. Ray HJ, Cong Y, Murthy AK, Selby DM, Klose KE, Barker JR, Guentzel MN, Arulanandam BP. 2009. Oral live vaccine strain-induced protective immunity against pulmonary Francisella tularensis challenge is mediated by CD4+ T cells and antibodies, including immunoglobulin A. Clin. Vaccine Immunol. 16:444-452.
16. Cole LE, Yang Y, Elkins KL, Fernandez ET, Qureshi N, Shlomchik MJ, Herzenberg LA, Vogel SN. 2009. Antigen-specific B-1a antibodies induced by Francisella tularensis LPS provide long-term protection against F. tularensis LVS challenge. Proc. Natl. Acad. Sci. U. S. A. 106:4343-4348.
17. Kirimanjeswara GS, Olmos S, Bakshi CS, Metzger DW. 2008. Humoral and cell-mediated immunity to the intracellular pathogen Francisella tularensis. Immunol. Rev. 225:244-255.
18. Duckett NS, Olmos S, Durrant DM, Metzger DW. 2005. Intranasal interleukin-12 treatment for protection against respiratory infection with the Francisella tularensis live vaccine strain. Infect. Immun. 73:2306-2311.
19. Chen W, KuoLee R, Shen H, Conlan JW. 2004. Susceptibility of immunodeficient mice to aerosol and systemic infection with virulent strains of Francisella tularensis. Microb. Pathog. 36:311-318.
20. Sjostedt A, North RJ, Conlan JW. 1996. The requirement of tumour necrosis factor-alpha and interferon-gamma for the expression of protective immunity to secondary murine tularaemia depends on the size of the challenge inoculum. Microbiology 142:1369-1374.
21. Leiby DA, Fortier AH, Crawford RM, Schreiber RD, Nacy CA. 1992. In vivo modulation of the murine immune response to Francisella tularensis LVS by administration of anticytokine antibodies. Infect. Immun. 60:84-89.
22. Anthony LS, Ghadirian E, Nestel FP, Kongshavn PA. 1989. The requirement for gamma interferon in resistance of mice to experimental tularemia. Microb. Pathog. 7:421-428.
23. Rhinehart-Jones TR, Fortier AH, Elkins KL. 1994. Transfer of immunity against lethal murine Francisella infection by specific antibody depends on host gamma interferon and T cells. Infect. Immun. 62:3129-3137.
24. Alugupalli KR. 2008. A distinct role for B1b lymphocytes in T cellindependent immunity. Curr. Top. Microbiol. Immunol. 319:105-130.
25. Crane DD, Griffin AJ, Wehrly TD, Bosio CM. 2013. B1a cells enhance susceptibility to infection with virulent Francisella tularensis via modulation of NK/NKT cell responses. J. Immunol. 190:2756-2766.
26. Zhang Y, Pacheco S, Acuna CL, Switzer KC, Wang Y, Gilmore X, Harriman GR, Mbawuike IN. 2002. Immunoglobulin A-deficient mice exhibit altered T helper 1-type immune responses but retain mucosal immunity to influenza virus. Immunology 105:286-294.
27. Harriman GR, Bogue M, Rogers P, Finegold M, Pacheco S, Bradley A, Zhang Y, Mbawuike IN. 1999. Targeted deletion of the IgA constant region in mice leads to IgA deficiency with alterations in expression of other Ig isotypes. J. Immunol. 162:2521-2529.
28. Epstein LB, Ammann AJ. 1974. Evaluation of T lymphocyte effector function in immunodeficiency diseases: abnormality in mitogenstimulated interferon in patients with selective IgA deficiency. J. Immunol. 112:617-626.
29. Cowan MJ, Fujiwara P, Ammann AJ. 1980. Cellular immune defect in selective IgA deficiency using a microculture method for PHA stimulation and limiting dilution. Clin. Immunol. Immunopathol. 17:595-605.
30. Hooper LV, Gordon JI. 2001. Commensal host-bacterial relationships in the gut. Science 292:1115-1118.
31. Ichinohe T, Pang IK, Kumamoto Y, Peaper DR, Ho JH, Murray TS, Iwasaki A. 2011. Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc. Natl. Acad. Sci. U. S. A. 108:5354-5359.